Number of the records: 1  

HPMA copolymer mebendazole conjugate allows systemic administration and possesses antitumour activity in vivo

  1. 1.
    SYSNO0558143
    TitleHPMA copolymer mebendazole conjugate allows systemic administration and possesses antitumour activity in vivo
    Author(s) Studenovský, Martin (UMCH-V) [BIOMOL] RID, ORCID
    Rumlerová, Anna (UMCH-V) [BIOMOL]
    Kovářová, Jiřina (MBU-M)
    Dvořáková, Barbora (MBU-M) RID
    Sivák, Ladislav (MBU-M) RID
    Kostka, Libor (UMCH-V) [BIOMOL] RID, ORCID
    Berdár, Daniel (MBU-M)
    Etrych, Tomáš (UMCH-V) [BIOMOL] RID, ORCID
    Kovář, Marek (MBU-M) RID, ORCID
    Corespondence/seniorStudenovský, Martin - Korespondující autor
    Kovář, Marek - Korespondující autor
    Source Title Pharmaceutics. Roč. 14, č. 6 (2022). - : MDPI
    Article number1201
    Document TypeČlánek v odborném periodiku
    Grant GA19-05649S GA ČR - Czech Science Foundation (CSF), CZ - Czech Republic
    LTAUSA18083 GA MŠMT - Ministry of Education, Youth and Sports (MEYS), CZ - Czech Republic
    JSPS-22-01, CZ - Czech Republic, JP - Japan
    Institutional supportUMCH-V - RVO:61389013 ; MBU-M - RVO:61388971
    Languageeng
    CountryCH
    Keywords mebendazole * drug delivery * cancer therapy
    URLhttps://www.mdpi.com/1999-4923/14/6/1201
    Permanent Linkhttps://hdl.handle.net/11104/0333076
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.